Investigation of a Novel Approach to Improve Treatment Success Rates for Tuberculosis Patients in Senegal
1 other identifier
interventional
1,500
1 country
1
Brief Summary
Tuberculosis (TB) patients who receive inadequate treatment or do not complete therapy are more likely to remain infectious, thus contributing to the continuous spread of TB infection in communities. Despite the widespread use of Directly Observed Therapy, defaulters remain an important problem in TB control programmes. In Sénégal, defaulters rate reach 30%, which is hampering dramatically the effectiveness of control. New strategies to deliver treatment to TB patients and ensure proper adherence that are adapted to the local situations are urgently needed. Objectives The overall objective of the project is to improve tuberculosis treatment success rates in Sénégal. The specific objectives are:
- Phase 1: baseline assessment of the TB situation.
- Phase 2: anthropological study, investigating various domains contributing to patients cure using a range of qualitative research methods. At the end of this investigation, it is expected that determinants of care will be clearly identified. On this basis, suitable methods for improving patients' adherence to treatment will be tailored and developed.
- Phase 3: these methods will be tested and compared using a cluster randomised controlled trial design, in populations served by defined health centres. Their efficacy will be measured in terms of improvement of the classical TB control programme indicators (cure rate, defaulter rate, failure rate, death rates). The methods will also be evaluated on their acceptability by the TB patients and the communities and on their feasibility (duration : 24 months). Expected results: Methods to improve patients' adherence to treatment that are affordable, acceptable and sustainable will be developed and tested according to qualitative and quantitative criteria.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_4
Started May 2003
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2003
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2005
CompletedFirst Submitted
Initial submission to the registry
December 14, 2006
CompletedFirst Posted
Study publicly available on registry
December 15, 2006
CompletedDecember 15, 2006
December 1, 2006
December 14, 2006
December 14, 2006
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
TB treatment success rate (cure + completed treatment)
Treatment defaulting rates
Secondary Outcomes (2)
treatment failure rate
death rate
Interventions
Eligibility Criteria
You may qualify if:
- newly diagnosed sputum-smear positive pulmonary TB (at least two positive specimens), aged 15 years or more, and living in the district served by the District Health Centre.
You may not qualify if:
- Smear-negative tuberculosis cases
- extra-pulmonary tuberculosis cases
- TB re-treatment cases
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Programme National de Lutte Anti-tuberculeuse
Dakar, Senegal
Related Publications (2)
Lienhardt C, Ogden JA. Tuberculosis control in resource-poor countries: have we reached the limits of the universal paradigm? Trop Med Int Health. 2004 Jul;9(7):833-41. doi: 10.1111/j.1365-3156.2004.01273.x.
PMID: 15228495BACKGROUNDThiam S, LeFevre AM, Hane F, Ndiaye A, Ba F, Fielding KL, Ndir M, Lienhardt C. Effectiveness of a strategy to improve adherence to tuberculosis treatment in a resource-poor setting: a cluster randomized controlled trial. JAMA. 2007 Jan 24;297(4):380-6. doi: 10.1001/jama.297.4.380.
PMID: 17244834DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Moustapha Ndir, MD
Programme de Lutte anti-tuberculeuse, Dakar, Senegal
- PRINCIPAL INVESTIGATOR
Christian Lienhardt, MD
Institut de Recherche pour le Developpement, Paris, France
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
Study Record Dates
First Submitted
December 14, 2006
First Posted
December 15, 2006
Study Start
May 1, 2003
Study Completion
January 1, 2005
Last Updated
December 15, 2006
Record last verified: 2006-12